
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Geng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Linda N. Geng is a Clinical Associate Professor of Medicine at Stanford University School of Medicine, specializing in internal medicine with a focus on Long COVID and other complex, puzzling conditions. Dr. Geng holds dual degrees — an M.D. and a Ph.D. in Molecular and Cellular Biology — from the University of Washington, and earned her B.S. in Biochemistry/Cell Biology and B.A. in Psychology, summa cum laude, from Rice University. She completed her internal medicine residency and served as Chief Resident at Stanford University. She is board-certified by the American Board of Internal Medicine.
Clinically and academically, Dr. Geng’s work centers on undiagnosed and rare diseases, diagnostic excellence, and post-infectious syndromes, particularly Long COVID. She is Co-Founder and Co-Director of the Stanford Long COVID Collaborative, a multidisciplinary clinical and research program that aims to advance care and understanding of Long COVID. Dr. Geng leads a broad portfolio of research studies including clinical trials evaluating therapeutic strategies and published in high profile journals such as NEJM and JAMA. Dr. Geng also participates in national consortia and expert advisory groups focused on establishing research agendas, care guidelines, and treatment development for Long COVID.
Education & Training
University of Washington School of MedicineClass of 2015
Certifications & Licensure
CA State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Alpha Omega Alpha Medical Honors Society
Publications & Presentations
PubMed
- Plasma Extracellular Vesicle Surface Marker Profiling Reveals Immune Cell-Associated Mitochondrial Membrane Potential Alterations in Long COVID and Myalgic Encephalomy...Gentaro Ikeda, Mariko Koike-Ieki, Hiroyuki Inoue, Arya V Dadhania, Vanessa El Kamari
Open Forum Infectious Diseases. 2026-05-01 - 1 citationsEmpiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.Abigail Glascock, Cole Maguire, Hoang Van Phan, Emily C Lydon, Joanna Schaenman
Nature Microbiology. 2026-04-01 - Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, Annmarie Hoch, Jeremy P Gygi
Communications Medicine. 2026-02-23
Press Mentions
As Understanding of Long COVID Deepens, the Search for Therapies ContinuesNovember 7th, 2025
Cutbacks Force Long-COVID Clinic Closures: What Now?October 1st, 2025
Women Are at Much Higher Risk of Long COVID Than Men. Why?March 25th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









